Genetron Holdings Limited logo
Genetron Holdings Limited GTH

Annual report 2022
added 12-21-2024

report update icon

Genetron Holdings Limited Balance Sheet 2011-2026 | GTH

Annual Balance Sheet Genetron Holdings Limited

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

- -1.35 B -121 M - -42 M - - - - - -

Long Term Debt

- - 5.49 M 3.64 M - - - - - - - -

Long Term Debt Current

21.5 M 20.6 M 16.6 M 15.4 M - - - - - - - -

Total Non Current Liabilities

- - 48.5 M 2.14 B 1.32 B 1.02 B - - - - - -

Total Liabilities

427 M 308 M 277 M 2.35 B 1.39 B 1.06 B - - - - - -

Deferred Revenue

- - 8.42 M 18.2 M 8.87 M 3.4 M - - - - - -

Retained Earnings

- - -4.94 B -1.84 B -1.17 B -703 M - - - - - -

Total Assets

975 M 1.52 B 1.97 B 574 M 324 M 441 M - - - - - -

Cash and Cash Equivalents

176 M 639 M 1.38 B 140 M 140 M - - - - - - -

Book Value

548 M 1.21 B 1.69 B -1.78 B -1.06 B -622 M - - - - - -

Total Shareholders Equity

- - 1.69 B -1.78 B -1.06 B - - - - - - -

All numbers in CNY currency

Quarterly Balance Sheet Genetron Holdings Limited

2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

- - - - 33.9 M - - - 43 M - - - 29.1 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Non Current Liabilities

- - - - 42.5 M - - - 48.5 M - - - 2.14 B - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Liabilities

- - - - 308 M - - - 277 M - - - 2.35 B - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Retained Earnings

- - - - -5.44 B - - - -4.94 B - - - -1.84 B - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Assets

- - - - 1.52 B - - - 1.97 B - - - 574 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cash and Cash Equivalents

- - - - 639 M - - - 1.38 B - - - 140 M - - - 62.1 M - - - 42 M - - - - - - - - - - - - - - - - - - - - - - - - - - -

Book Value

- - - - 1.21 B - - - 1.69 B - - - -1.78 B - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Shareholders Equity

- - - - 1.21 B - - - 1.69 B - - - -1.78 B - - - -1.06 B - - - -622 M - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in CNY currency

Balance Sheet is a fundamental financial report of Genetron Holdings Limited, providing a complete picture of the company’s financial position at a specific point in time. Unlike the income statement, which records the results of operations over a certain period, the balance sheet shows what assets the company owns, what liabilities it has to creditors, and what equity is available to the owners.

For an investor, the balance sheet is important because it allows assessing the company’s financial stability, understanding how much debt it carries, and how dependent it is on borrowed financing. It helps calculate key liquidity and leverage ratios. When analyzing, attention should be paid to the debt-to-equity ratio (Debt/Equity), the amount of cash on the balance sheet, and the ratio of current liabilities to liquid assets.

Features of balance sheet analysis
  • Vertical and horizontal analysis
    Vertical analysis shows the structure of the balance sheet as a percentage of total assets or liabilities, while horizontal analysis shows the dynamics of changes over multiple periods.
  • Asset quality
    It is important to evaluate not only the amount of assets but also their liquidity and realizability.
  • Accounting for off-balance sheet liabilities
    Some liabilities may not be directly reflected in the balance sheet, which requires additional attention.

Balance sheet of other industry stocks – Diagnostics research

Issuer Price % 24h Market Cap Country
Agilent Technologies Agilent Technologies
A
$ 121.02 1.7 % $ 36.8 B usaUSA
Anixa Biosciences Anixa Biosciences
ANIX
$ 2.96 4.71 % $ 96.1 K usaUSA
Centogene N.V. Centogene N.V.
CNTG
- -6.23 % $ 30.6 M germanyGermany
Aspira Women's Health Aspira Women's Health
AWH
- -6.19 % $ 10.5 M usaUSA
Burning Rock Biotech Limited Burning Rock Biotech Limited
BNR
$ 22.3 -5.27 % $ 234 M chinaChina
Celcuity Celcuity
CELC
$ 111.31 3.64 % $ 4.39 B usaUSA
Akumin Akumin
AKU
- -17.87 % $ 25.9 M canadaCanada
Castle Biosciences Castle Biosciences
CSTL
$ 28.14 2.07 % $ 782 M usaUSA
Oxford Immunotec Global PLC Oxford Immunotec Global PLC
OXFD
- - $ 562 M britainBritain
Heska Corporation Heska Corporation
HSKA
- - $ 1.31 B usaUSA
HTG Molecular Diagnostics HTG Molecular Diagnostics
HTGM
- -20.0 % $ 1.06 M usaUSA
Charles River Laboratories International Charles River Laboratories International
CRL
$ 180.97 2.92 % $ 8.97 B usaUSA
Fulgent Genetics Fulgent Genetics
FLGT
$ 14.14 2.56 % $ 428 M usaUSA
Accelerate Diagnostics Accelerate Diagnostics
AXDX
- -61.36 % $ 2.46 M usaUSA
Global Cord Blood Corporation Global Cord Blood Corporation
CO
- - $ 399 M chinaChina
Fluidigm Corporation Fluidigm Corporation
FLDM
- 1.08 % $ 308 M usaUSA
Genetic Technologies Limited Genetic Technologies Limited
GENE
- - $ 7.1 B australiaAustralia
PRA Health Sciences, Inc. PRA Health Sciences, Inc.
PRAH
- - $ 10.7 B usaUSA
Motus GI Holdings Motus GI Holdings
MOTS
- -34.28 % $ 263 K israelIsrael
Biodesix Biodesix
BDSX
$ 14.71 -5.1 % $ 1.91 B usaUSA
Biocept Biocept
BIOC
- -13.05 % $ 7.29 M usaUSA
IDEXX Laboratories IDEXX Laboratories
IDXX
$ 650.0 2.28 % $ 52.3 B usaUSA
Invitae Corporation Invitae Corporation
NVTA
- - $ 21.2 M usaUSA
Illumina Illumina
ILMN
$ 129.59 0.02 % $ 20.6 B usaUSA
BioNano Genomics BioNano Genomics
BNGO
$ 1.14 1.88 % $ 1.45 M usaUSA
Quest Diagnostics Incorporated Quest Diagnostics Incorporated
DGX
$ 208.63 0.13 % $ 23.2 B usaUSA
Danaher Corporation Danaher Corporation
DHR
$ 205.32 0.63 % $ 146 B usaUSA
Organovo Holdings Organovo Holdings
ONVO
- -2.3 % $ 19.4 M usaUSA
Exact Sciences Corporation Exact Sciences Corporation
EXAS
$ 103.51 0.13 % $ 19.5 B usaUSA
Bioventus Bioventus
BVS
$ 8.42 -3.66 % $ 527 M usaUSA
DarioHealth Corp. DarioHealth Corp.
DRIO
$ 9.65 -6.26 % $ 274 M israelIsrael
DexCom DexCom
DXCM
$ 73.39 0.42 % $ 28.6 B usaUSA
PerkinElmer PerkinElmer
PKI
- -0.91 % $ 14.7 B usaUSA
Psychemedics Corporation Psychemedics Corporation
PMD
- -1.84 % $ 15.3 M usaUSA
QIAGEN N.V. QIAGEN N.V.
QGEN
- - $ 10.6 B niderlandNiderland
Quotient Limited Quotient Limited
QTNT
- -11.32 % $ 1.1 M schweizSchweiz
ICON Public Limited Company ICON Public Limited Company
ICLR
$ 110.81 1.94 % $ 9.14 B irlandaIrlanda
Renalytix AI plc Renalytix AI plc
RNLX
- 5.66 % $ 22.7 M britainBritain
CareDx, Inc CareDx, Inc
CDNA
$ 19.28 2.56 % $ 1.03 B usaUSA
Chembio Diagnostics Chembio Diagnostics
CEMI
- 0.22 % $ 16.8 M usaUSA
Laboratory Corporation of America Holdings Laboratory Corporation of America Holdings
LH
$ 281.11 -0.69 % $ 23.4 B usaUSA
Lantheus Holdings Lantheus Holdings
LNTH
$ 77.74 -1.4 % $ 5.25 B usaUSA
Check-Cap Ltd. Check-Cap Ltd.
CHEK
- - $ 9.42 M israelIsrael
Guardant Health Guardant Health
GH
$ 93.95 0.7 % $ 11.8 B usaUSA
IQVIA Holdings IQVIA Holdings
IQV
$ 177.49 2.0 % $ 30.5 B usaUSA
Mettler-Toledo International Mettler-Toledo International
MTD
$ 1 290.77 -1.92 % $ 26.6 B schweizSchweiz
Brainsway Ltd. Brainsway Ltd.
BWAY
$ 12.53 8.11 % $ 99.4 M israelIsrael
Co-Diagnostics Co-Diagnostics
CODX
- - $ 79.8 M usaUSA
Myriad Genetics Myriad Genetics
MYGN
$ 5.35 1.04 % $ 495 M usaUSA